| 000 | 01401 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516091256.0 | ||
| 264 | 0 | _c20120529 | |
| 008 | 201205s 0 0 rus d | ||
| 022 | _a0869-6047 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShliakhto, E V | |
| 245 | 0 | 0 |
_a[Molecular and genetic aspects of heart failure in diabetic patients]. _h[electronic resource] |
| 260 |
_bVestnik Rossiiskoi akademii meditsinskikh nauk _c2012 |
||
| 300 |
_a31-7 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aBiotransformation _xgenetics |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aCardiovascular Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aDiabetes Complications _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aEarly Medical Intervention |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenomics |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aMetformin _xpharmacokinetics |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aMonitoring, Physiologic _xmethods |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aPrecision Medicine _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tVestnik Rossiiskoi akademii meditsinskikh nauk _gno. 1 _gp. 31-7 |
|
| 999 |
_c21747811 _d21747811 |
||